BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23948894)

  • 1. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
    Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
    J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated progression from mild cognitive impairment to dementia among APOE ε4ε4 carriers.
    Xu WL; Caracciolo B; Wang HX; Santoni G; Winblad B; Fratiglioni L
    J Alzheimers Dis; 2013; 33(2):507-15. PubMed ID: 23247007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 12 Years Preceding Mild Cognitive Impairment Due to Alzheimer's Disease: The Temporal Emergence of Cognitive Decline.
    Mistridis P; Krumm S; Monsch AU; Berres M; Taylor KI
    J Alzheimers Dis; 2015; 48(4):1095-107. PubMed ID: 26402083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cases with mild cognitive impairment and Alzheimer's disease fail to benefit from repeated exposure to episodic memory tests as compared with controls.
    Schrijnemaekers AM; de Jager CA; Hogervorst E; Budge MM
    J Clin Exp Neuropsychol; 2006 Apr; 28(3):438-55. PubMed ID: 16618630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A three-year follow-up study on the transfer of mild cognitive impairment to Alzheimer's disease among the elderly in Taiyuan city].
    Wang YP; Zhai JB; Zhu F; Zhang WW; Yang XJ; Qu CY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Feb; 32(2):105-9. PubMed ID: 21518614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is thyroid status associated with cognitive impairment in elderly patients in China?
    Hu Y; Wang ZC; Guo QH; Cheng W; Chen YW
    BMC Endocr Disord; 2016 Feb; 16():11. PubMed ID: 26897535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study.
    Pocnet C; Antonietti JP; Donati A; Popp J; Rossier J; von Gunten A
    Int Psychogeriatr; 2015 Aug; 27(8):1379-89. PubMed ID: 25592615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study.
    Godinho C; Camozzato AL; Onyszko D; Chaves ML
    Int Psychogeriatr; 2012 Apr; 24(4):674-81. PubMed ID: 22088617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smell identification function as a severity and progression marker in Alzheimer's disease.
    Velayudhan L; Pritchard M; Powell JF; Proitsi P; Lovestone S
    Int Psychogeriatr; 2013 Jul; 25(7):1157-66. PubMed ID: 23597130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational Attainment as Risk Factor for Progression from Mild Cognitive Impairment to Alzheimer's Disease: A CREDOS Study.
    Myung W; Lee C; Park JH; Woo SY; Kim S; Kim S; Chung JW; Kang HS; Lim SW; Choi J; Na DL; Kim SY; Lee JH; Han SH; Choi SH; Kim SY; Carroll BJ; Kim DK
    J Alzheimers Dis; 2017; 55(1):283-292. PubMed ID: 27662289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incident Cerebral Microbleeds Detected by Susceptibility Weight-Imaging Help to Identify Patients with Mild Cognitive Impairment Progressing to Alzheimer's Disease.
    Basselerie H; Bracoud L; Zeestraten E; Bouguen E; Kiyasova V; Pueyo M; Cognard C; Dumas H; Gramada R; Ousset PJ; Vellas B; Bonneville F
    J Alzheimers Dis; 2017; 60(1):253-262. PubMed ID: 28826188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
    Jessen F; Wolfsgruber S; Wiese B; Bickel H; Mösch E; Kaduszkiewicz H; Pentzek M; Riedel-Heller SG; Luck T; Fuchs A; Weyerer S; Werle J; van den Bussche H; Scherer M; Maier W; Wagner M;
    Alzheimers Dement; 2014 Jan; 10(1):76-83. PubMed ID: 23375567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
    Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
    J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-domain amnestic mild cognitive impairment identified by cluster analysis predicts Alzheimer's disease in the european prospective DESCRIPA study.
    Damian M; Hausner L; Jekel K; Richter M; Froelich L; Almkvist O; Boada M; Bullock R; De Deyn PP; Frisoni GB; Hampel H; Jones RW; Kehoe P; Lenoir H; Minthon L; Olde Rikkert MG; Rodriguez G; Scheltens P; Soininen H; Spiru L; Touchon J; Tsolaki M; Vellas B; Verhey FR; Winblad B; Wahlund LO; Wilcock G; Visser PJ
    Dement Geriatr Cogn Disord; 2013; 36(1-2):1-19. PubMed ID: 23651945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone loss and osteoporosis are associated with conversion from mild cognitive impairment to Alzheimer's disease.
    Zhou R; Zhou H; Rui L; Xu J
    Curr Alzheimer Res; 2014; 11(7):706-13. PubMed ID: 25115539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Montreal Cognitive Assessment Memory Index Score (MoCA-MIS) as a predictor of conversion from mild cognitive impairment to Alzheimer's disease.
    Julayanont P; Brousseau M; Chertkow H; Phillips N; Nasreddine ZS
    J Am Geriatr Soc; 2014 Apr; 62(4):679-84. PubMed ID: 24635004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.